I agree that this site is using cookies. You can find further informations here.
X
Stockerl-Goldstein, Keith
115  results:
Search for persons X
?
1

Prolonged CXCR4 Receptor Occupancy By Motixafortide Followi..:

Crees, Zachary D ; Stockerl-Goldstein, Keith ; Sorani, Ella...
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S390 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Motixafortide Enables Consistent, Robust Hematopoietic Stem..:

Crees, Zachary D ; Rettig, Michael P. ; Jayasinghe, Reyka...
Transplantation and Cellular Therapy.  30 (2024)  2 - p. S390-S391 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Continuous Elotuzumab, Pomalidomide, and Dexamethasone Main..:

Slade, Michael ; Fiala, Mark A. ; Kirchmeyer, Marie...
Transplantation and Cellular Therapy.  29 (2023)  12 - p. 764.e1-764.e7 , 2023
Link: https://doi.org/10.1016/..
 
?
4

A Single Reference Interval for Interpreting Serum Free Lig..:

Azimi, Vahid ; Slade, Michael ; Fiala, Mark...
Clinical Chemistry.  69 (2023)  6 - p. 595-605 , 2023
Link: https://doi.org/10.1093/..
 
?
5

Evaluation of the Simplified Score to Predict Early Relapse..:

Slade, Michael ; Fiala, Mark ; Kelley, Sarah...
Leukemia Research.  127 (2023)  - p. 107037 , 2023
Link: https://doi.org/10.1016/..
 
?
6

Venous Thromboembolism Risk in Patients With Newly Diagnose..:

Loncharich, Alexa J. ; Fiala, Mark A. ; Slade, Michael J....
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  11 - p. 825-828 , 2023
Link: https://doi.org/10.1016/..
 
?
7

Motixafortide and G-CSF to mobilize hematopoietic stem cell..:

Crees, Zachary D. ; Rettig, Michael P. ; Jayasinghe, Reyka G....
Nature Medicine.  29 (2023)  4 - p. 869-879 , 2023
Link: https://doi.org/10.1038/..
 
?
8

Phase I-II Trial of Early Azacitidine after Matched Unrelat..:

Xu, Ziheng ; Choi, Jaebok ; Cooper, Matthew...
Transplantation and Cellular Therapy.  29 (2023)  11 - p. 699.e1-699.e9 , 2023
Link: https://doi.org/10.1016/..
 
?
9

P-264 A phase 1b study of isatuximab and bendamustine for t..:

Goldsmith, Scott ; Slade, Michael ; Fiala, Mark...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S181 , 2023
Link: https://doi.org/10.1016/..
 
?
10

P-085 The use of clonotypic mass spectrometry for post-AHCT..:

Slade, Michael ; Khaled, Abir ; Fortier, Julie...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S81-S82 , 2023
Link: https://doi.org/10.1016/..
 
?
11

P-459 A randomized, controlled phase 2 trial of uproleselan..:

Crees, Zachary ; Stockerl-Goldstein, Keith ; Ryan, Meaghan...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S292-S293 , 2023
Link: https://doi.org/10.1016/..
 
?
12

Elotuzumab, Pomalidomide and Dexamethasone Maintenance afte..:

Slade, Michael ; Fiala, Mark A ; Kirchmeyer, Marie...
Transplantation and Cellular Therapy.  29 (2023)  2 - p. S397-S398 , 2023
Link: https://doi.org/10.1016/..
 
?
13

PB2122: A PHASE 1/2 MULTI-CENTER, DOSE-FINDING STUDY INVEST..:

Kastritis, Efstathios ; Matous, Jeffrey ; Berdeja, Jesus...
HemaSphere.  7 (2023)  S3 - p. e5544426 , 2023
Link: https://doi.org/10.1097/..
 
?
14

OAB-034: External validation of the simplified score to pre..:

Slade, Michael ; Fiala, Mark ; Kelley, Sarah...
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S20-S21 , 2022
Link: https://doi.org/10.1016/..
 
?
15

An overview of treatment options for patients with relapsed..:

Dimopoulos, Meletios A. ; Mikhael, Joseph ; Terpos, Evangelos...
Therapeutic Advances in Hematology.  13 (2022)  - p. 204062072210884 , 2022
Link: https://doi.org/10.1177/..
 
1-15